Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Murray

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Hybridoma|July 20, 2001
Generation and characterization of monoclonal antibodies to the neural crestT Shakil, M K Richardson, E Waldron, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated deathA Dutton, J D O'Neil, A E Milner, et al.
Leukemia|April 14, 2000
Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with ageK J Flavell, J P Biddulph, C M Constandinou, et al.
Enzyme and Microbial Technology|June 28, 2001
Isolation and characterization of a thermostable endo-beta-glucanase active on 1,3-1,4-beta-D-glucans from the aerobic fungus talaromyces emersonii CBS 814.70P G. Murray, A Grassick, C D. Laffey, et al.
Blood|January 15, 1996
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disordersP G Murray, L J Swinnen, C M Constandinou, et al.
The Journal of Pathology|June 16, 2001
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's diseaseP G Murray, J R Flavell, K R Baumforth, et al.
Blood|December 9, 2000
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical responseJ Yang, Q Tao, I W Flinn, et al.
The Journal of Pathology|March 23, 2000
Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1Z Kolar, J R Flavell, J Ehrmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's diseaseK J Flavell, L J Billingham, J P Biddulph, et al.
Blood|July 29, 1998
Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognitionS P Lee, C M Constandinou, W A Thomas, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Hybridoma|July 20, 2001
Generation and characterization of monoclonal antibodies to the neural crestT Shakil, M K Richardson, E Waldron, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated deathA Dutton, J D O'Neil, A E Milner, et al.
Leukemia|April 14, 2000
Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with ageK J Flavell, J P Biddulph, C M Constandinou, et al.
Enzyme and Microbial Technology|June 28, 2001
Isolation and characterization of a thermostable endo-beta-glucanase active on 1,3-1,4-beta-D-glucans from the aerobic fungus talaromyces emersonii CBS 814.70P G. Murray, A Grassick, C D. Laffey, et al.
Blood|January 15, 1996
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disordersP G Murray, L J Swinnen, C M Constandinou, et al.
The Journal of Pathology|June 16, 2001
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's diseaseP G Murray, J R Flavell, K R Baumforth, et al.
Blood|December 9, 2000
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical responseJ Yang, Q Tao, I W Flinn, et al.
The Journal of Pathology|March 23, 2000
Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1Z Kolar, J R Flavell, J Ehrmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's diseaseK J Flavell, L J Billingham, J P Biddulph, et al.
Blood|July 29, 1998
Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognitionS P Lee, C M Constandinou, W A Thomas, et al.
Pageof 13